IP Library › Patent Application 17066885
Patent Application
App. No. 17/066,885

NOVEL COMPOSITIONS AND METHODS FOR CANCER TREATMENT

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
17/066,885
Abstract

The present invention relates to the composition and method of use of Stat3 pathway inhibitors or cancer stem cell inhibitors in combination treatment of cancer.

Claims (5)

1 . A method for treating cancer in a human subject in need thereof comprising administering to said subject

a therapeutically effective amount of synthetic 2-acetylnaphtho[2,3-b]furan-4,9-dione, and

a therapeutically effective amount of at least one agent chosen from bevacizumab, bortezomib, capecitabine, cetuximab, fluorouracil, imatinib, irinotecan, leucovorin, oxaliplatin, panitumumab, pemetrexed, temozolomide, cisplatin, paclitaxel, erlotinib, sunitinib, lapatinib, sorafenib, carboplatin, doxorubicin, docetaxel, gemcitabine, and etoposide,

wherein said cancer is pancreatic cancer or colorectal cancer,

wherein said cancer expresses activated STAT3.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 22, 2020
From: LI, CHIANG JIA; MIKULE, KEITH; LI, YOUZHI
To: BOSTON BIOMEDICAL, INC.
Reel/Frame 054140/0769 →
CHANGE OF NAME Recorded Oct 22, 2020
From: BOSTON BIOMEDICAL, INC.
To: SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
Reel/Frame 054181/0536 →